ReviewCancers2023
Current Status of Angiogenesis Inhibitors as Second-Line Treatment for Unresectable Colorectal Cancer.
Satoshi Otsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it